staking crypto Archives - Coin Engineer

Which Altcoins Are Accumulating on Exchanges This Month?

Yeliz Akmaca — Fri, 22 Aug 2025 14:30:24 +0000

In mid-August, some altcoins drew attention as exchange reserves decreased. This trend indicates that investors are withdrawing coins from exchanges to hold in their wallets. This behavior was particularly noticeable in projects like ENA, BIO, and API3, which attracted increased investor interest for various reasons.

Ethena (ENA) Rises Amid Buyback Program

Ethena (ENA) price surged 30% in August while exchange reserves dropped by 150 million ENA. This decline coincided with Ethena Foundation’s $260 million buyback program, which purchases around 5 million ENA daily.

Ethena’s revenue exceeded $500 million, and the USDe supply reached a record level. These developments strengthen investor confidence, making long-term holding more attractive.

BIO Protocol and Demand Driven by Staking

BIO Protocol, a prominent project in the DeSci sector, rose 265% in August. During this period, exchange reserves fell from 380 million BIO to 294 million BIO, a significant 22% drop. In the third week, investors withdrew 42 million BIO in just one week.

BIO’s staking program accumulated 25 million tokens, and Arthur Hayes’ $1 million investment drew attention to the project. Additionally, the BioXP reward system encourages users to promote the project on social media, further boosting interest and accumulation.

API3 and Momentum in the Oracle Sector

API3 rose 130% in August, and exchange reserves fell to their lowest level of the year. In the third week, 9 million API3 tokens were withdrawn, bringing reserves down to 17.19 million. The Upbit listing contributed to this surge.

The oracle sector in general attracted investor focus. Chainlink’s (LINK) rally highlighted similar projects. According to Artemis data, August was the best-performing period for oracle projects. API3 accumulation helped stabilize the price above $1.50.

These three altcoins demonstrated a selective altcoin rally in August. Buyback programs, staking incentives, and listings were key factors driving investor interest. In summary, ENA, BIO, and API3 showed strong accumulation signals alongside declining exchange reserves.

You can also freely share your thoughts and comments about the topic in the comment section. Additionally, don’t forget to follow us on our Telegram, YouTube, and Twitter channels for the latest news and updates.

The post Which Altcoins Are Accumulating on Exchanges This Month? appeared first on Coin Engineer.

Quantum Biopharma Strengthens Bitcoin Holdings With $1M Crypto Purchase

Yigit Taha OZTURK — Tue, 20 May 2025 12:00:05 +0000

The financial playbook of biotech firms is undergoing a transformation. No longer content with traditional assets, companies are now turning to digital currencies like Bitcoin to diversify their portfolios and hedge against currency depreciation.

Quantum Biopharma, a Canadian biotechnology company, has announced the purchase of $1 million in Bitcoin and other cryptocurrencies. According to a press release dated May 19, this move brings the firm’s total crypto holdings to approximately $4.5 million.

A Crypto Treasury Strategy Emerges in Biotech

The company also revealed plans to stake a portion of its digital assets to generate additional revenue. According to management, this strategy aims to provide returns for shareholders and act as a hedge against the weakening Canadian dollar.

You Might Be Interested In: Elon Musk Talks About the Name of a New Memecoin!

Following the announcement, shares of Quantum Biopharma (QNTM) surged by around 25%, reflecting investor optimism toward the firm’s crypto-focused financial strategy.

Biotech Companies Turning to Bitcoin

Quantum is part of a growing trend among healthcare companies embracing Bitcoin as a strategic asset. Back in March, Atai Life Sciences, a NASDAQ-listed biotech firm, unveiled plans to purchase $5 million worth of Bitcoin. Its founder, Christian Angermayer, stated, “Bitcoin should be part of any corporate treasury—especially in the biotech sector.”

On May 16, Basel Medical Group, a Singapore-based healthcare provider, disclosed its intent to buy $1 billion in Bitcoin. However, unlike Quantum, Basel’s stock took a significant hit after the announcement.

As of May 19, corporate treasuries collectively hold over $83 billion in Bitcoin, according to BitcoinTreasuries.NET. Public companies now rank as the second-largest institutional holders of Bitcoin, trailing only exchange-traded funds (ETFs).

According to Fidelity Digital Assets, Bitcoin can serve as a “valuable hedge against growing fiscal deficits, currency debasement, and geopolitical risks.”

The post Quantum Biopharma Strengthens Bitcoin Holdings With $1M Crypto Purchase appeared first on Coin Engineer.